Skip to main content

Table 8 Comparison of ΔT between Group A or B and HCs

From: Dose–effect of long-snake-like moxibustion for chronic fatigue syndrome: a randomized controlled trial

Sites

Time /ΔT

Group A

(n = 30)

Group B

(n = 30)

HCs

(n = 30)

Median (CI)*

Median (CI)**

Upper Jiao

Baseline

0.32 (− 0.01, 0.56)

0.36 (0.05, 0.54)

0.35 (0.19, 0.58)

0.05 (− 0.18, 0.25)

0.07 (− 0.19, 0.22)

Week 4

0.43 (0.26, 0.69)

0.43 (0.07, 0.57)

0.35 (0.19, 0.58)

− 0.08 (− 0.25, 0.09)

− 0.02 (− 0.19, 0.21)

Middle Jiao

Baseline

− 0.22 (− 0.71, 0.14)

− 0.33 (− 0.99, 0.09)

0.07 (− 0.11, 0.25)

0.35 (0.10, 0.64)

0.44 (0.15, 0.79)

Week 4

0.06 (− 0.02, 0.26)

0.00 (− 0.06, 0.24)

0.07 (− 0.11, 0.25)

0.00 (− 0.18, 0.10)

0.10 (− 0.15, 0.14)

Lower Jiao

Baseline

− 0.67 (− 1.37, − 0.29)

− 0.81 (− 1.89, − 0.41)

− 0.38 (− 0.64, − 0.12)

0.37 (0.06, 0.76)

0.44 (0.18, 0.82)

Week 4

− 0.47 (− 0.66, − 0.05)

− 0.57 (− 0.70, − 0.39)

− 0.38 (− 0.64, − 0.12)

0.03 (− 0.21, 0.25)

0.17 (− 0.01, 0.33)

Shenque

(CV8)

Baseline

0.57 (− 0.06, 0.91)

0.57 (0.06, 1.17)

1.17 (0.73, 1.78)

0.74 (0.34, 1.13)

0.68 (0.31, 1.11)

Week 4

1.29 (0.85, 2.07)

1.12 (0.95, 1.42)

1.17 (0.73, 1.78)

− 0.12 (− 0.54, 0.27)

0.00 (− 0.29, 0.30)

Zhongwan

(CV12)

Baseline

− 0.84 (− 1.43, − 0.17)

− 0.91 (− 2.07, − 0.16)

− 0.15 (− 1.19, 0.19)

0.47 (− 0.07, 1.00)

0.65 (0.10, 1.12)

Week 4

− 0.50 (− 0.92, − 0.11)

− 0.53 (− 0.92, − 0.23)

− 0.15 (− 1.19, 0.19)

0.14 (− 0.47, 0.59)

0.17 (− 0.34, 0.64)

Danzhong

(CV17)

Baseline

0.45 (− 0.11, 1.08)

0.35 (− 0.06, 0.80)

0.65 (0.40, 1.11)

0.19 (− 0.16, 0.53)

0.34 (0.05, 0.64)

Week 4

0.53 (0.10, 0.80)

0.53 (0.08, 0.82)

0.65 (0.40, 1.11)

0.19 (− 0.08. 0.45)

0.26 (− 0.08, 0.54)

Governor vessel

Baseline

0.58 (0.36, 0.91)

0.53 (− 0.01, 0.79)

0.74 (0.40, 1.13)

0.10 (− 0.17, 0.36)

0.31 (0.00, 0.61)

Week 4

0.60 (0.41, 1.00)

0.68 (0.44, 0.88)

0.74 (0.40, 1.13)

0.08 (− 0.16, 0.32)

0.04 (− 0.17, 0.31)

Pishu

(BL20)

Baseline

0.39 (0.09, 0.73)

0.15 (− 0.55, 0.36)

0.40 (0.14, 0.70)

0.02 (− 0.22, 0.30)

0.37 (0.08, 0.74)

Week 4

0.40 (0.27, 0.74)

0.31 (0.18, 0.42)

0.40 (0.14, 0.70)

− 0.06 (− 0.30, 0.10)

0.08 (− 1.00, 0.30)

Shenshu

(BL23)

Baseline

0.45 (0.21, 0.92)

0.16 (− 0.22, 0.54)

0.51 (0.14, 0.97)

0.06 (− 0.24, 0.36)

0.42 (0.13, 0.69)

Week 4

0.56 (0.51, 0.87)

0.52 (0.25, 0.60)

0.51 (0.14, 0.97)

− 0.11 (− 0.38, 0.16)

0.06 (-0.16, 0.34)

Neck

Baseline

0.68 (− 0.40, 1.48)

0.41 (− 0.08, 0.89)

1.41 (0.74, 1.99)

0.84 (0.29, 1.46)

1.13 (0.66, 1.56)

Week 4

0.89 (0.82, 1.79)

0.85 (0.72, 1.31)

1.41 (0.74, 1.99)

0.28 (− 0.17, 0.78)

0.42 (0.09, 0.88)

 Upper arm

Baseline

− 0.42 (− 1.07, 0.15)

− 0.42 (− 0.81, − 0.18)

0.24 (− 0.42, 0.66)

0.48 (0.04, 0.93)

0.64 (0.20, 1.00)

Week 4

− 0.20 (− 0.98, 0.45)

− 0.25 (− 0.98, 0.17)

0.24 (− 0.42, 0.66)

0.34 (− 0.34, 0.82)

0.50 (0.01, 0.85)

Thoracic segments

Baseline

0.33 (− 0.24, 0.85)

0.31 (− 0.41, 0.64)

0.76 (0.53, 1.07)

0.44 (0.17, 0.77)

0.60 (0.31, 0.93)

Week 4

0.66 (0.54, 1.02)

0.66 (0.51, 0.86)

0.76 (0.53, 1.07)

0.06 (− 0.13, 0.29)

0.11 (− 0.40, 0.33)

Lumbar segments

Baseline

0.35 (− 0.06, 0.82)

0.21 (− 0.12, 0.54)

0.49 (0.22, 0.83)

0.18 (− 0.08, 0.43)

0.35 (0.13, 0.58)

Week 4

0.63 (0.57, 0.93)

0.59 (0.43, 0.72)

0.49 (0.22, 0.83)

− 0.15 (− 0.37, 0.04)

− 0.09 (− 0.23, 0.11)

Renal region

Baseline

− 0.08 (− 0.77, 0.30)

− 0.32 (− 1.12, 0.03)

0.07 (− 0.13, 0.35)

0.22 (− 0.04, 0.52)

0.49 (0.21, 0.82)

Week 4

0.11 (− 0.02, 0.41)

0.04 (− 0.20, 0.12)

0.07 (− 0.13, 0.35)

− 0.06 (− 0.26, 0.14)

0.08 (− 0.11, 0.23)

  1. Group A: Long-snake-like moxibustion for 60 min; Group B: Long-snake-like moxibustion for 30 min. Bold data represented statistical differences in ΔT of Groups A and B compared to HCs.  Data were presented as Median (Q1, Q3); Q: quarter; Q1: 25th percentile; Q3: 75th percentile. 
  2. HCs Healthy control subjects; 95%CI 95% Confidence Interval
  3. * Group A vs. HCs, ** Group B vs. HCs. Hodges-Lehmann method was used to calculate median differences and their 95% confidence intervals